SCHEMBL14712209

SCHEMBL14712209

N[C@@]12CCC1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8215826 0.85
SCHEMBL12231800 0.78
SCHEMBL19250369 0.76
SCHEMBL19645440 0.74 KDM4E (0.32)
SCHEMBL21090063 0.74 KDM4E (0.32)
SCHEMBL24725969 0.74
SCHEMBL20878295 0.74 KDM4E (0.32)
SCHEMBL20878262 0.74 KDM4E (0.32)
SCHEMBL18808899 0.74
SCHEMBL11888287 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130046009-A1 RHO KINASE INHIBITORS FOR TREATMENT OF MASTOCYTOSIS AND ACUTE MYELOID LEUKEMIA NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-02-21 US disclosed